Earlier this month, the company launched its first DNA-encoded library of its proprietary macromolecules, which it hopes will ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Australian synthetic biologists have developed a prototype for an innovative biosensor that can detect rare earth elements and be modified for a range of other applications.

Researchers at Durham University have achieved a major advancement in understanding how proteins bind metals inside cells, a process crucial to life. The study, published in Nature Communications, ...

A research group at Umeå University has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This research opens doors to new methods for ...

It’s been trained on 771 billion unique tokens – the AI term for a unit of data – taken from databases of natural protein ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

EZH1 is a key regulator of circadian rhythms, stabilizing gene transcription and modifying chromatin to maintain genetic ...

DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.